Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Improved delayed visual reproduction test performance in multiple sclerosis patients receiving interferon beta-1b

N H Pliskin1, D P Hamer, D S Goldstein

  • 1Department of Psychiatry, University of Chicago Pritzker School of Medicine, Chicago, USA.

Neurology
|December 1, 1996
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Baseline brain function in the preadolescents of the ABCD Study.

Nature neuroscience·2021
Same author

Tetanus.

The Indian medical gazette·2017
Same author

Antibacterial action of doped CoFe2O4 nanocrystals on multidrug resistant bacterial strains.

Materials science & engineering. C, Materials for biological applications·2015
Same author

Genetic variation near IRF8 is associated with serologic and cytokine profiles in systemic lupus erythematosus and multiple sclerosis.

Genes and immunity·2013
Same author

Interferon-beta-1b-induced short- and long-term signatures of treatment activity in multiple sclerosis.

The pharmacogenomics journal·2012
Same author

Neuro-QOL: brief measures of health-related quality of life for clinical research in neurology.

Neurology·2012

High-dose interferon beta-1b (IFN-beta-1b) therapy significantly improved memory recall in multiple sclerosis (MS) patients. This cognitive benefit in MS was observed without changes in brain lesion area or disability scores.

Area of Science:

  • Neuroscience
  • Immunology
  • Clinical Neurology

Background:

  • Multiple sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system.
  • Cognitive dysfunction is a common and debilitating symptom in MS patients.
  • Interferon beta-1b (IFN-beta-1b) is an established treatment for MS, but its effects on cognition require further elucidation.

Purpose of the Study:

  • To longitudinally assess the impact of interferon beta-1b (IFN-beta-1b) on neuropsychological function in patients with multiple sclerosis (MS).
  • To investigate the relationship between cognitive changes, MRI-measured brain lesion area, and clinical disability scores in MS patients treated with IFN-beta-1b.

Main Methods:

  • A longitudinal study involving 30 MS patients from a pivotal trial of IFN-beta-1b.

Related Experiment Videos

  • Patients were randomized to high-dose IFN-beta-1b (8.0 million units), low-dose IFN-beta-1b (1.6 MIU), or placebo.
  • Neuropsychological tests (Wechsler Memory Scale), MRI, and Expanded Disability Status Scale (EDSS) were assessed over 4 years.

    • Main Results:

    • Significant improvement in visual memory recall (Wechsler Memory Scale Visual Reproduction-Delayed Recall) was observed in the high-dose IFN-beta-1b group between years 2 and 4.
    • No significant correlation was found between cognitive improvement, motor performance, MRI lesion area, or depression scores.
    • While the high-dose group showed stable lesion area, placebo and low-dose groups exhibited increased lesion area over time.
    • EDSS scores remained stable and did not correlate with MRI lesion area.

    Conclusions:

    • High-dose IFN-beta-1b therapy demonstrates a positive effect on specific aspects of cognitive function, namely delayed visual memory recall, in MS patients.
    • This cognitive improvement is independent of changes in brain lesion burden or overall clinical disability.
    • The findings suggest a potential disease-modifying effect of high-dose IFN-beta-1b on cognitive function in MS, not attributable to practice effects or lesion changes.